Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2013
04/11/2013WO2013050280A1 Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis
04/11/2013WO2013050204A1 Assay for clostridium botulinum neurotoxin
04/11/2013WO2013049975A1 Kit and method for detecting mutation of predetermined site in dna sample and use thereof
04/11/2013WO2013049926A1 PROGNOSTIC MARKERS OF INHERITED VARIATIONS IN THE 17β-HYDROXYSTEROID DEHYDROGENASE (HSD17B) GENES FOR PROSTATE CANCER
04/11/2013WO2013049892A1 Diagnostic assay for tissue transplantation status
04/11/2013WO2013049891A1 Compositions and methods of detecting respiratory pathogens using nucleic acid probes and subsets of beads
04/11/2013WO2013025322A3 Marker-based prognostic risk score in liver cancer
04/11/2013WO2013024024A3 Quality assessment of induced pluripotent cells by referring to splicing signatures of pluripotency
04/11/2013WO2013016114A3 Enzymatic cleavage based lateral flow assays
04/11/2013WO2013015717A3 Method for determining the activity of a proteolytic enzyme (variants), device for the implementation of same and diagnostic method
04/11/2013WO2013003350A3 Microrna biomarkers indicative of alzheimer's disease
04/11/2013WO2012174484A3 Identifying markers of caloric restriction and caloric restriction mimetics
04/11/2013WO2012174119A3 Compositions and methods for detection of cronobacter spp. and cronobacter species and strains
04/11/2013WO2012158502A3 Compositions and methods for a mycobacterium tuberculosis drug susceptibility test
04/11/2013WO2012150818A3 Method for predicting a risk of chronic myeloid leukemia, and diagnosis kit using same
04/11/2013WO2012083249A3 Dna sequencing by synthesis using modified nucleotides and nanopore detection
04/11/2013US20130091601 Nucleic acid molecules that target rpa70 and confer resistance to coleopteran pests
04/11/2013US20130091600 Nucleic acid molecules that target pp1-87b and confer resistance to coleopteran pests
04/11/2013US20130091591 Artery- and vein-specific proteins and uses therefor
04/11/2013US20130090471 Method for detecting compounds that modulate the cholesterol metabolism
04/11/2013US20130090470 Optically-detectable enzyme substrates and their method of use
04/11/2013US20130090382 Methods, assays, and kits related to dichloroacetate (dca)
04/11/2013US20130090329 Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature
04/11/2013US20130090262 SELECTIVE ENRICHMENT OF CpG ISLANDS
04/11/2013US20130090261 Device for Determining or Studying the State of Stimulation of the Natural Defences of Plants or Portions of Plants
04/11/2013US20130090260 Multiplexed Assay Using Spectrally-Encoded Solid Support Matrices
04/11/2013US20130090259 Improved method for selecting high producing cell lines
04/11/2013US20130090258 Method for detecting colorectal tumor
04/11/2013US20130090257 Pathway analysis for providing predictive information
04/11/2013US20130090256 Biomarkers for early detection of ovarian cancer
04/11/2013US20130090255 Biological Markers of Chronic Wound Tissue and Methods of Using for Criteria in Surgical Debridement
04/11/2013US20130090254 Gene-expression profiling with reduced numbers of transcript measurements
04/11/2013US20130090252 Quantitative, Highly Multiplexed Detection of Nucleic Acids
04/11/2013US20130090251 Tumour Markers
04/11/2013US20130090250 Assay systems for genetic analysis
04/11/2013US20130090248 Selection of compartmentalised screening
04/11/2013US20130089927 Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof
04/11/2013US20130089920 Microfluidic flow cell
04/11/2013US20130089915 DNA Sequences For Regulating Transcription
04/11/2013US20130089913 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
04/11/2013US20130089909 Binding a target substance
04/11/2013US20130089891 Apparatus for chemiluminescent assay and detection
04/11/2013US20130089890 Apparatus and method for analyzing a contaminated surface
04/11/2013US20130089887 Method for Rapid Detection and Identification of micro-colonies using impregnated porous material
04/11/2013US20130089886 Method for direct and rapid identification of microorganisms and antimicrobial susceptibility testing from positive blood cultures
04/11/2013US20130089883 Quick method for detecting enyzmes and microoranisms
04/11/2013US20130089881 Testing a mammal for presence, progression or stage of a shock condition
04/11/2013US20130089880 Method for Diagnosing Acute Cardiac Ischemia
04/11/2013US20130089879 Compositions and methods for diagnosing and monitoring disease and treatment via antigen-specific molecules
04/11/2013US20130089871 Marker for detection and/or discrimination of non-alcoholic steatohepatitis, method for detection and/or discrimination of non-alcoholic steatohepatitis, and kit for use in the method
04/11/2013US20130089866 Kit For Detection of Genes Targeted by MicroRNA, and Method For Detection of Genes Targeted by MicroRNA
04/11/2013US20130089864 Methods for characterizing kidney function
04/11/2013US20130089863 Risk calculation for evaluation of fetal aneuploidy
04/11/2013US20130089862 Genetic Lesion Associated With Cancer
04/11/2013US20130089861 Detection of Immune Cells, In Particular T Cells Through DNA-Methylation Analysis of the Genes CCR6 and BLR1
04/11/2013US20130089860 Comparative transcript analysis
04/11/2013US20130089859 Compositions, methods and kits to detect adenovirus nucleic acids
04/11/2013US20130089857 Method for detecting the presence of specific micro-organisms and device for the same
04/11/2013US20130089855 Method of characterizing vascular diseases
04/11/2013US20130089853 Fluorescent dyes
04/11/2013US20130089563 Method of diagnosing and treating cancer
04/11/2013US20130089558 Dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
04/11/2013US20130089536 Pharmaceutical composition to prevent and treat alzheimer's disease comprising gcp ii mutant
04/11/2013US20130089519 Method for Predicting a Therapy Response in Subjects with Multiple Sclerosis
04/11/2013DE102011054334A1 Verfahren zur Bestimmung der Interaktion zwischen einem Polynucleotid und Blutplättchenfaktor 4 Method for determining the interaction between a polynucleotide and platelet factor 4
04/11/2013CA2850930A1 Methods and devices for assessing risk to a putative offspring of developing a condition
04/11/2013CA2850785A1 Methods and processes for non-invasive assessment of genetic variations
04/11/2013CA2850781A1 Methods and processes for non-invasive assessment of genetic variations
04/11/2013CA2850668A1 Srm/mrm assay for the ephrin type-a receptor 2 protein
04/11/2013CA2850646A1 Prognosis for glioma
04/11/2013CA2849098A1 Assay for clostridium botulinum neurotoxin
04/11/2013CA2843775A1 Methods for diagnosing and identifying modulators of membrane potentials in bipolar disorder and attention deficit hyperactivity disorder
04/10/2013EP2579040A2 Qualitative and quantitative analytical method for analyzing the activity type of an enzyme that is activated by proteolysis
04/10/2013EP2579031A1 Biosensor for measuring blood component and hematocrit.
04/10/2013EP2578702A1 System and method for correcting primer extension errors in nucleic acid sequence data
04/10/2013EP2578701A1 Probe, polymorphism detection method, method of evaluating drug efficacy or tolerance, and reagent kit
04/10/2013EP2578700A1 In vitro diagnostic method for patients with splenic marginal zone lymphoma
04/10/2013EP2578699A1 Methods for detection of risk of obesity and risk of onset of diabetes
04/10/2013EP2578698A1 Genetic polymorphisms associated with venous thrombosis in women, methods of detection and uses thereof
04/10/2013EP2578697A1 Estimation of drug-metabolizing capacity
04/10/2013EP2578696A1 MiRNAs as non-invasive biomarkers for diagnosis
04/10/2013EP2578695A1 Assay for Clostridium botulinum Neurotoxin
04/10/2013EP2578694A1 Fluorescent substrate for detection of enzymatic activity of nitrile-related enzyme
04/10/2013EP2578693A1 Method for detecting bacteria
04/10/2013EP2578692A1 Agents that reduce neuronal overexcitation
04/10/2013EP2578683A1 Aptamer therapeutics useful in the treatment of complement-related disorders
04/10/2013EP2578678A1 Method for producing tumor cell
04/10/2013EP2578676A1 Tissue modeling in multi- or pluripotent cell systems
04/10/2013EP2578674A1 Biological-sample affixing device
04/10/2013EP2578601A1 Immuno-based botulinum toxin serotype A activity assays
04/10/2013EP2578232A1 Treatment drug for autoimmune diseases and allergic diseases
04/10/2013EP2578229A1 Decreasing potential iatrogenic risks associated with vaccine antigens
04/10/2013EP2577319A2 Fluid flow contour control using flow resistance
04/10/2013EP2577318A2 Method of nociceptor differentiantion of human embryonic stem cells and uses thereof
04/10/2013EP2577306A1 Molecular classification of multiple myeloma
04/10/2013EP2577305A1 Methods for identifying compositions that alter wildtype expression of genes and proteins in a plant cell
04/10/2013EP2577300A2 Scanning multifunctional particles
04/10/2013EP2577299A2 Filtration methods and devices
04/10/2013EP2577297A2 Methods of diagnosing asthma
04/10/2013EP2577275A1 Optical mapping of genomic dna